Antimicrobial therapy in experimental pseudomonas infection

M. Z. Thomas, P. M. Southern

Research output: Contribution to journalArticle

Abstract

Young adult mice were infected with recent clinical isolates of Pseudomonas aeruginosa (P.a.). The LD50 in utreated mice was 6.7 X 107 organisms for one strain (MS2) and 2.5 X 107 organisms for the other (MZT624). Non infected injected controls all survived. Mortality in utreated controls was 73% (MS2) and 83% (MZT624). Treated animals received carbenicillin (CA), colistimethate (CO), gentamicin (GE) or polymyxin B (PB), either singly or in various combinations. MS2 infections were significantly ameliorated by CA or PB singly (53% and 40% mortality) and by several combinations (12.5% to 45% mortality). MZT624 infections were significantly altered by GE, GE plus PB, and by 2 3 drug regimens (29% to 43% mortality). In this model CA, GE, and PB were the most effective single anti P.a. agents; CA plus PB or GE, and GE plus PB were the most effective 2 drug combinations. No instances of in vivo synergism were observed.

Original languageEnglish (US)
Pages (from-to)569-577
Number of pages9
JournalTexas Reports on Biology and Medicine
Volume32
Issue number2
StatePublished - 1974

Fingerprint

Pseudomonas Infections
Polymyxin B
Investigational Therapies
Carbenicillin
Gentamicins
Mortality
Pseudomonas aeruginosa
Lethal Dose 50
Drug Combinations
Infection
Young Adult
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Antimicrobial therapy in experimental pseudomonas infection. / Thomas, M. Z.; Southern, P. M.

In: Texas Reports on Biology and Medicine, Vol. 32, No. 2, 1974, p. 569-577.

Research output: Contribution to journalArticle

@article{c9c22c7ac83947beb57d1b385a7d3121,
title = "Antimicrobial therapy in experimental pseudomonas infection",
abstract = "Young adult mice were infected with recent clinical isolates of Pseudomonas aeruginosa (P.a.). The LD50 in utreated mice was 6.7 X 107 organisms for one strain (MS2) and 2.5 X 107 organisms for the other (MZT624). Non infected injected controls all survived. Mortality in utreated controls was 73{\%} (MS2) and 83{\%} (MZT624). Treated animals received carbenicillin (CA), colistimethate (CO), gentamicin (GE) or polymyxin B (PB), either singly or in various combinations. MS2 infections were significantly ameliorated by CA or PB singly (53{\%} and 40{\%} mortality) and by several combinations (12.5{\%} to 45{\%} mortality). MZT624 infections were significantly altered by GE, GE plus PB, and by 2 3 drug regimens (29{\%} to 43{\%} mortality). In this model CA, GE, and PB were the most effective single anti P.a. agents; CA plus PB or GE, and GE plus PB were the most effective 2 drug combinations. No instances of in vivo synergism were observed.",
author = "Thomas, {M. Z.} and Southern, {P. M.}",
year = "1974",
language = "English (US)",
volume = "32",
pages = "569--577",
journal = "Texas Reports on Biology and Medicine",
issn = "0040-4675",
number = "2",

}

TY - JOUR

T1 - Antimicrobial therapy in experimental pseudomonas infection

AU - Thomas, M. Z.

AU - Southern, P. M.

PY - 1974

Y1 - 1974

N2 - Young adult mice were infected with recent clinical isolates of Pseudomonas aeruginosa (P.a.). The LD50 in utreated mice was 6.7 X 107 organisms for one strain (MS2) and 2.5 X 107 organisms for the other (MZT624). Non infected injected controls all survived. Mortality in utreated controls was 73% (MS2) and 83% (MZT624). Treated animals received carbenicillin (CA), colistimethate (CO), gentamicin (GE) or polymyxin B (PB), either singly or in various combinations. MS2 infections were significantly ameliorated by CA or PB singly (53% and 40% mortality) and by several combinations (12.5% to 45% mortality). MZT624 infections were significantly altered by GE, GE plus PB, and by 2 3 drug regimens (29% to 43% mortality). In this model CA, GE, and PB were the most effective single anti P.a. agents; CA plus PB or GE, and GE plus PB were the most effective 2 drug combinations. No instances of in vivo synergism were observed.

AB - Young adult mice were infected with recent clinical isolates of Pseudomonas aeruginosa (P.a.). The LD50 in utreated mice was 6.7 X 107 organisms for one strain (MS2) and 2.5 X 107 organisms for the other (MZT624). Non infected injected controls all survived. Mortality in utreated controls was 73% (MS2) and 83% (MZT624). Treated animals received carbenicillin (CA), colistimethate (CO), gentamicin (GE) or polymyxin B (PB), either singly or in various combinations. MS2 infections were significantly ameliorated by CA or PB singly (53% and 40% mortality) and by several combinations (12.5% to 45% mortality). MZT624 infections were significantly altered by GE, GE plus PB, and by 2 3 drug regimens (29% to 43% mortality). In this model CA, GE, and PB were the most effective single anti P.a. agents; CA plus PB or GE, and GE plus PB were the most effective 2 drug combinations. No instances of in vivo synergism were observed.

UR - http://www.scopus.com/inward/record.url?scp=0016287898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016287898&partnerID=8YFLogxK

M3 - Article

VL - 32

SP - 569

EP - 577

JO - Texas Reports on Biology and Medicine

JF - Texas Reports on Biology and Medicine

SN - 0040-4675

IS - 2

ER -